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ABSTRACT 
Health development target in 2025 is increasing community health status with decrease of Maternal Mortality Rate 
(MMR) indicator from 262 per 100,000 live births in 2005 to 74 per 100,000 live births in 2025. The Increasing of the 
incidence of deaths due to preeclampsia, the cause is not known with certainty, so there is no agreement on the strategy 
to prevent preeclampsia. Study aims was to determine the risk factors for preeclampsia in RSKDIA Pertiwi Makassar 
with age, blood type, and body mass index. Research design used an analytic survey with retrospective case control. 
Samples was 90 respondent with a ratio 1:2 for the case and control groups, taken by purposive sampling with data 
completeness criteria. Data analysis using the STATA program, test was carried out with Odds Ratio (OR) with a 
significant level of <0.05. The results was a relationship between age and preeclampsia, p value = 0.04, age was a risk 
factor where women aged <20 or >35 years have a 2,667 times risk had preeclampsia. Results of statistical tests did not 
find a relationship between incidence of preeclampsia with blood type and body mass index, but women with BMI ≥30 
had 2.093 times the risk of developing preeclampsia compared to women with BMI <30. In this study, age and BMI are 
risk factors of preeclampsia, and blood type is a protective factor. Recommended, early detection with a risk factor 
approach, clients are expected to be more active in seeking information and recognizing risk factors for preeclampsia. 
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INTRODUCTION  
Preeclampsia is one of the leading 
causes of maternal death in the world. The 
high maternal mortality rate in this case is 
mostly due to inadequate management at the 
basic service level so that patients are referred 
in an already severe condition, improving the 
quality of midwifery services at the basic 
service level is expected to improve the 
prognosis for mothers and babies 
According to WHO predictions, the 
incidence of preeclampsia cases with 
complications occurring is seven times higher 
in developing countries than in developed 
countries, the prevalence ratio is 14%:1.8% 
(Osungbade and Ige, 2011). In 2011 the 
incidence of preeclampsia in Indonesia was 
128,273 events, around 5.3% of the entire 
population of maternity mothers in Indonesia 
(Noroyono et al., 2016). 
The Increasing incidence of death due to 
preeclampsia until now the cause is not known 
with certainty, so that there is no agreement in 
preeclampsia prevention strategies. Therefore, 
early detection of preeclampsia is very 
necessary, especially to improve the quality of 
care in pregnancy. Activities for early 
detection and handling of pregnant women at 
risk/midwifery complications need to be 
further improved both in Maternal and Child 
Health (KIA) service facilities and in the 
community.  
Data on preeclampsia cases reported at 
the South Sulawesi Provincial Health Office in 
2017 were 1966 cases with 40 deaths (34.78%) 
of the total 115 deaths in South Sulawesi 
(Selatan, 2018). The initial survey conducted 
by the author at the Regional Special Hospital 
for Mothers and Children (RSKDIA) Pertiwi 
Makassar, recorded that there were 89 cases of 
preeclampsia in 2017, which tended to 
decrease compared to 2016 and 2015 of 146 
and 114, respectively case. 
Based on the description above, it 
inspires the author to continue research in the 
hope of providing additional more accurate 
information, especially risk factors that are 
easily identified. 
Question of this study are age, blood 
type, and maternal body mass index a risk 
factor for the incidence of preeclampsia at 
RSKDIA Pertiwi Makassar. Objectives of this 
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study is to determine the risk factors that 
caused preeclampsia in RSKDIA Pertiwi 
Makassar. 
 
MATERIAL AND METHOD 
Replication of research on risk factors 
for the incidence of preeclampsia has been 
widely carried out, both by domestic and 
foreign researchers. These studies have 
contributed directly or indirectly to health 
policy. In this study, researchers limit the 
variables to be studied, namely the risk factors 
for the incidence of preeclampsia in terms of 
age, blood type and maternal body mass index 
because these variables can be easily 
identified directly by health workers or 
individually by the pregnant woman 
concerned. 
Type of research carried out is an 
analytic survey study with retrospective case 
control approach. This study retrospective was 
conducted by tracing back the risk factors for 
the incidence of preeclampsia. 
This design is used by considering the 
availability of the sample population at the 
research site and the dependent variable to be 
studied is an obstetric complication which in 
principle is very undesirable to occur. So that 
by using this design, it is possible to select a 
case group and a control group involved in the 
study to see which risk factors play a role.  
Case and control groups were selected 
from the same source population so that both 
groups had comparable characteristics except 
for disease status. 
The research was conducted in RSKDIA 
Pertiwi Makassar, consideration of the 
location easily accessible to transport because 
it is located in the city center of Makassar 
administration. RSKDIA is a Type B referral 
hospital owned by the government of South 
Sulawesi Province with Main Level Hospital 
Accreditation status. 
Study population was all mothers who 
gave birth recorded in the medical records at 
RSKDIA Pertiwi Makassar from January to 
December 2018.  
Ratio of cases to controls is set at 1: 2 so 
that from the above formula the number of 
samples needed for the case group is 30 and 
for the control group is 60 with matching 
delivery status, it was primipara.  
 
RESULT AND DISCUSSION 
The data taken was secondary data 
contained in the recording of patient medical 
records and other supporting documents in the 
form of a MCH book.  
The number of deliveries at RSKDIA 
Pertiwi in 2018 was 3578 with complications 
of preeclampsia as many as 127 cases so that 
the number of samples collected until the end 
of the study was sufficient, 30 people for the 
case group and 60 people for the control group 
where the total sample was 90 people. 
1. Univariate Analysis Univariate 
Analysis in this study is to describe each 
independent variable presented in the form of 
a frequency distribution table so that it can be 
read clearly the distribution of each risk factor 
for each sample group. 
 
Table 1 Distribution of subjects by age, blood 
type and BMI at RSKDIA Pertiwi Makassar in 
2018 
 





n % n % 
 
< 20 4 13.33 6 10.00 10 
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20 – 35 20 66.67 48 80.00 68 
> 35 6 20.00 6 10.00 12 
Total 30 100.00 60 100.00 90 
Blood n % n % 
 
A 6 20.00 14 23.33 20 
B 3 10.00 12 20.00 15 
AB 6 20.00 6 10.00 12 
O 15 50.00 28 46.67 43 
Total 30 100.00 60 100.00 90 




30 11 36.67 13 21.67 24 
≤ 30 19 63.33 47 78.33 66 
Total 30 100.00 60 100.00 90 
Secondary Data, 2018 
Table 1 above shows that the largest subjects 
are in the healthy reproductive age group, 
which is 66.67% for the case group and 80% 
for the control group. The 35-year-old group 
consisted of 6 people, both the control group 
and the control group, with percentages of 
20% and 10%, respectively. For study subjects 
aged < 20 years, 4 people (13.33) in the case 
group and 6 people (10%) in the control 
group. The age grouping in the table above is 
based on healthy reproductive age, where it is 
said that the healthy reproductive age is in the 
age range of 20-35 years, at that time the 
maturity and reproductive readiness of women 
have been perfect both physically and 
psychologically. 
The distribution of subjects based on blood 
type, both case and control group, blood group 
O is the dominant blood group, 15 people 
(50%) and 28 people (46.67%), the lowest was  
Blood group B as many as 3 people (10%) 
in the case group and blood type AB as many 
as 6 people (23.33%) in the control group. 
Blood type A were 6 people (20%) in the case 
group and 14 people (23.33%) in the control 
group. The table above shows the distribution 
of blood groups in research subjects, where 
the majority of the blood group in the 
population is blood type O, although in this 
study no specific determination was made for 
blood type. 
Provides an overview of the subject's body 
mass index, where body mass index 30 as 
many as 19 people (63.33%) for the case 
group and 47 people (78.33%) for the control 
group , while body mass index > 30 as many 
as 11 people (36.67%) in the case group and 
13 people (21.67%) in the control group. 
2. Bivariate Analysis 
At this stage, an analysis of the relationship 
between each independent variable and the 
dependent variable is carried out.  
 
Table 2 Relationship of age, blood type, 
and BMI with the incidence of preeclampsia 
at RSKDIA Pertiwi Makassar in 2018 





High Risk 12 12 24 p=0.040;OR=2,
667 
Low Risk 18 48 66 95% CI= 0.903 
- 7.809 
Total 30 60 90 PFE=62.5%; 
PFP=25% 
Blood Type    
High Risk 15 32 47 p=0.765;OR=0.
875 
Low Risk 15 28 43 95%CI= 0.332 
- 2.307 
Total 30 60 90 PFE = 12.5%; 
PFP = 6.7% 
BMI    
High Risk 11 13 24 p=0.129;OR=2,
093 
Low Risk 19 47 66 95%CI = 0.707 
- 6.077 
Total 30 60 90 PFE = 12.5%; 
PFP = 6.7% 
Secondary Data, 2018   
Table 2, it can be seen that there is a 
significant relationship between age and the 
incidence of preeclampsia as evidenced by the 
results of the statistical test p value = 0.04 ; 
95% Confident Interval (CI). The value of 
Odds Ratio (OR) = 2.667 means that in this 
study age is a risk factor for the occurrence of 
preeclampsia, where women aged <20 or >35 
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years are at risk of 2,667 times experiencing 
preeclampsia compared to women aged 20-35 
years. The Prevalence Fraction of Exposure 
(PFE) states that as many as 62.5% of women 
aged <20 or >35 years are at risk of 
developing preeclampsia, and as much as 25% 
(Prevalence Fraction of Population/ PFP) of 
the total population regardless of age group is 
at risk of preeclampsia. 
Based on the results of statistical tests, 
table above shows that the incidence of 
preeclampsia with blood type has no 
statistically significant relationship as seen 
from the p value = 0.765 which is greater than 
the p value = 0.05 with a significance level of 
95% (0.332 till 2.307). So it can be interpreted 
that the alternative hypothesis is rejected and 
the null hypothesis is accepted. Although not 
statistically significant, bood type variable in 
this study can be said to be a protective factor 
against the incidence of preeclampsia, by 
looking at the value of OR = 0.875, it means 
that women with blood type O can avoid the 
incidence of preeclampsia by 1.14 times 
compared to women with blood type O (A, B, 
and AB). However, 12.5% (PFE) of women 
with blood type non-O are at risk of 
developing preeclampsia and about 6.7% 
(PFP) of the entire population is at risk of 
developing preeclampsia. 
The results of the analysis of body mass 
index risk factors for the incidence of 
preeclampsia are shown in table 5.6, using 
thetest the odds ratio results OR = 2.093 
means that body mass index is a risk factor for 
preeclampsia. Even though statistically there 
was no significant relationship between these 
variables, it was shown by the p value = 0.129 
(95% CI = 0.707 till 6.077). The estimated 
magnitude of women with a body mass index 
>30 to experience preeclampsia is 12.5% and 
6.7% of the total population, respectively. 
Preeclampsia is a condition that only 
occurs during pregnancy and can aggravate 
pregnancy and childbirth. Complications that 
occur can lead to eclampsia and can end in 
death. Preeclampsia is more common in 
mothers with risk factors for age, parity, 
mothers with obesity, mothers with multiple 
pregnancies, mothers with hydatidiform 
moles, and can also occur in pregnant women 
with unfavorable lifestyles, such as drinking 
alcoholic beverages, consuming foods with 
high levels of high salt and cholesterol, and 
consume fast food.  
Age is the length of time a person lives 
which is calculated from birth to the time the 
research is conducted. Age is categorized into 
2, unhealthy reproductive age (<20 years and 
>35 years) and healthy reproductive age (20-
35 years). 
Causes of maternal death from 
reproductive factors include maternal age. In 
the period of healthy reproduction, it is known 
that the safe age for pregnancy and childbirth 
is 20-30 years. Maternal mortality in pregnant 
women and childbirth at the age of under 20 
years was 2 to 5 times higher than maternal 
deaths that occurred at the age of 20 to 29 
years. Maternal mortality increases again after 
the age of 30 to 35 years. Age of 20–30 years 
is the safest period for pregnancy/delivery, but 
in developing countries around 10%-20% of 
babies are born to adolescent mothers who are 
slightly older than children. Where as from a 
study it was found that two years after the first 
menstruation, a woman is still likely to 
achieve pelvic growth between 2-7% and 1% 
in height. Age factors affect the occurrence of 
preeclampsia, the age of adolescent women in 
their first pregnancy or nulliparas in their teens 
(young age less than 20 years) are more at risk 
of suffering from preeclampsia. 
In this study, preeclampsia is defined as 
respondents who were clinically and 
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diagnostic disease characterized preeclampsia 
with blood pressure> 140/90 accompanied by 
proteinuria and edema and who have been 
diagnosed by a specialist in obstetrics and 
gynecology. 
Age of the mother during pregnancy is 
one of the factors that determine the level of 
risk of pregnancy and childbirth. Women aged 
<20 years and >35 years have a high risk of 
developing preeclampsia. This is in 
accordance with research conducted by 
(Nursal, Tamela and Fitrayeni, 2017) which 
showed that extreme age is a risk factor for 
severe preeclampsia (RP= 1,476; CI= 1,094 – 
1,922). The same result was also shown by 
(Primadhani and Supanji Raharja, 2017) 
which stated that age <20 years had a 1.6 
times higher risk of death due to preeclampsia, 
age >35 years had a 1.2 times risk and for ages 
20-35 years had a risk of death due to 
preeclampsia. is 0.87 times.  
Rresults of the statistical analysis of this 
study showed that there was no significant 
relationship between blood type and the 
incidence of preeclampsia, as seen from the 
results of the analysis chi square withvalue  p 
= 0.765 which was greater than the p value = 
0.05 95% significance level (0.332 – 2.307). 
The value of OR = 0.875 (OR < 1) means that 
blood type is a protective factor for the 
incidence of preeclampsia, so it can be said 
that women with blood type O can avoid the 
incidence of preeclampsia by 1.14 times 
compared to women with blood type O (A, B, 
and AB). ). However, 12.5% (PFE) of women 
with blood type non-O are at risk of 
developing preeclampsia and about 6.7% 
(PFP) of the entire population is at risk of 
developing preeclampsia. 
Results of this study are in line with the 
research which did not find a significant 
comparison of the distribution of blood 
grouping on the incidence of preeclampsia 
(Hentschke et al., 2014). Other studies 
(Franchini, Mengoli and Lippi, 2016) have not 
been able to determine how much influence 
blood type has on the severity of 
preeclampsia. Previous researchers in the team 
have done a similar study with the results of 
non-O blood group are risk factors for 
preeclampsia are the non- O blood type as the 
risk of severe preeclampsia compared blood 
group O, that AB has 7 times the risk of 
developing severe preeclampsia compared to 
blood type O (Sonda et al., 2016). 
Seeing comparison of some results of 
research that has been done before that has not 
been consistent so that the necessary further 
research in the form of a meta-analysis study 
of previous studies to describe the strengths 
and weaknesses of each research result so that 
a conclusion can be obtained in this regard. 
Blood type is a factor that cannot be 
changed, so that it remains attached to each 
individual, to avoid the risks that may arise, 
several preventive measures can be taken, 
including minimizing situations that can 
trigger mental stress and close supervision in 
giving dietary calcium during pregnancy as 
needed. 
One of the factors that is closely related 
to the occurrence of preeclampsia is obesity. 
Based on a study conducted on a population of 
pregnant women in Pittsburgh, it was found 
that the risk of preeclampsia increased 
threefold in obese pregnant women. addition, 
it was also explained that the incidence of 
preeclampsia at the end of pregnancy was 
more commonly found in overweight or obese 
women. One way to identify the presence of 
overweight or obesity in adults is to use the 
body mass index  
Free radical theory related to body mass 
index on the incidence of preeclampsia 
explains that the more weight you gain, the 
more lipid peroxides increase, while 
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antioxidants in pregnancy decrease, resulting 
in the dominance of relatively high levels of 
lipid peroxides (Tapowolo, Lalandos and 
Kareri, 2018) 
Maternal body mass index is a factor 
that influences pregnancy. Therefore, it is 
better to determine the benchmark for the 
amount of weight gain from before pregnancy 
until the end of pregnancy. Assessing weight 
before pregnancy is very important in terms of 
health for both mother and baby. If pregnant 
women are overweight before pregnancy, then 
the recommended increase should be smaller 
than pregnant women with ideal body weight. 
Pregnant women who have excessive weight 
gain will be at risk of pregnancy 
complications, one of which is preeclampsia. 
In addition, the accumulation of excessive 
body fat will make it difficult to lose weight 
after giving birth. Vice versa, women who 
were underweight before becoming pregnant, 
then when they are pregnant they need to gain 
more weight than mothers with ideal body 
weight. Reduced nutritional intake will inhibit 
the growth of the fetus in the womb such as 
low birth weight and other pregnancy 
disorders. Weight gain during pregnancy 
depends on weight before pregnancy. The best 
thing to do is to prepare for an ideal body 
weight before getting pregnant, so that the 
body will store all the nutrients needed by the 
body during pregnancy, such as carbohydrates, 
proteins, fats, vitamins, and minerals in 
balanced amounts. The recommended rate of 
weight gain is 1 to 2 kg during the first 
trimester and then 0.4 kg per week for women 
of normal weight and height (BMI 18.5 – 
24.9).  
Pregnancy is not the time to go on a diet. 
For women who are lean and care deeply 
about their shape (BMI 18.4), weight gain is a 
major problem. Maternal placentas that are not 
adequately nourished, often contain fewer 
cells that are measured smaller and are less 
able to synthesize nutrients needed by the 
fetus. 
Mother should be briefed on the effects 
of inadequate nutrition on fetal development. 
This counseling should include information 
about the recommended components of weight 
gain and how much of this gain will be lost 
during delivery. An explanation of how to lose 
weight in postpartum, helps relieve anxiety in 
mothers. Ideally, women who are obese (BMI 
30) should undergo a weight loss program 
prior to conception. However, all women need 
to gain weight during pregnancy. The increase 
in weight must be at least equal to the weight 
of the products of conception (fetus, placenta, 
amniotic fluid). The quality of this weight gain 
should be emphasized in nutrient-rich foods 
and avoiding low-calorie foods. 
Based on the results of several studies 
conducted regarding the relationship between 
body mass index and the incidence of 
preeclampsia, (Walsh, 2007), Obesity class II–
III was associated with a four-fold increased 
risk of mild to moderate preeclampsia 
(adjusted OR 4.0; 95% CI 3.7–4.4) (Sohlberg 
et al., 2012). Stated that excess body weight in 
pregnant women is associated with 
preeclampsia found that each increase in BMI 
before pregnancy led to an 8% increase in the 
risk of preeclampsia (Roberts et al., 2011). 
Results of research conducted on 30 
people in the case group and 60 people in the 
control group did not find a significant 
relationship as with several previous studies. 
Although not statistically significant the value, 
p= 1.29 (95% CI = 0.707 - 6.077), using odds 
ratio test, results obtained OR = 2.093, 
meaning that body mass index is a risk factor 
for the incidence of preeclampsia, obese 
pregnant women (BMI> 30) 2,093 times risk 
of experiencing preeclampsia compared to 
pregnant women with BMI <30. Estimated 




Urban Health. Vol.3 No. 1 (2021) 
magnitude of women with a body mass index 
>30 to experience preeclampsia is 12.5% and 
6.7% of total population, respectively. 
Avalue p> 0.05 was considered a 
relationship or association between risk factors 
and outcomes that were not statistically 
significant. However, it should be noted that 




Age is a risk factor for incidence of 
preeclampsia, with an Odds Ratio (OR) = 
2.667 it’s mean that women aged <20 or >35 
years are at risk of 2.667 times having 
preeclampsia compared to women aged 20-35 
years. 
Variable blood type in this study is not a 
risk factor but a protective factor against the 
incidence of preeclampsia, based on analysis 
data we found OR value = 0.875, it means that 
women with blood type O can avoid the 
incidence of preeclampsia by 1.14 times 
compared to women with blood type non O (A,  
B, and AB).  
Body mass index is a risk factor for the 
incidence of preeclampsia OR=2.093 means 
that pregnant women with a BMI 30 are at risk 
of developing preeclampsia 2.093 times. 
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